These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 651963)

  • 1. The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer.
    Lippman ME; Allegra JC; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC; Warren R
    N Engl J Med; 1978 Jun; 298(22):1223-8. PubMed ID: 651963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between steroid hormone receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC; Warren R
    Cancer Treat Rep; 1978 Sep; 62(9):1281-6. PubMed ID: 688273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer.
    Kiang DT; Frenning DH; Goldman AI; Ascensao VF; Kennedy BJ
    N Engl J Med; 1978 Dec; 299(24):1330-4. PubMed ID: 714108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of estrogen receptor status on response to combination chemotherapy for recurrent breast cancer.
    Mortimer J; Reimer R; Greenstreet R; Groppe C; Bukowski R
    Cancer Treat Rep; 1981; 65(9-10):763-6. PubMed ID: 7273011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of estrogen receptor status in predicting the response of carcinoma of the breast to adjuvant chemotherapy.
    Stephens RB; Abeloff MD; Mellits ED; Baker RR
    Surg Gynecol Obstet; 1982 Feb; 154(2):200-4. PubMed ID: 6277024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metastatic breast cancers: comparison of the prognostic significance and the sensitivity to chemotherapy according to the presence of estradiol and progesterone receptors].
    Pouillart P; Madgelenat H; Jouve M; Palangie T; Garcia-Giralt E; Bretaudeau B; Polijcak M; Asselain B
    Bull Cancer; 1982; 69(5):461-7. PubMed ID: 7165808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.
    Berns EM; Foekens JA; Vossen R; Look MP; Devilee P; Henzen-Logmans SC; van Staveren IL; van Putten WL; Inganäs M; Meijer-van Gelder ME; Cornelisse C; Claassen CJ; Portengen H; Bakker B; Klijn JG
    Cancer Res; 2000 Apr; 60(8):2155-62. PubMed ID: 10786679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal receptors and response to treatment of breast cancer: a retrospective evaluation in 60 patients.
    Loven D; Rakowsky E; Stein JA; Geier A; Lunenfeld B
    Isr J Med Sci; 1981; 17(9-10):960-4. PubMed ID: 7309485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic tumor markers, lymph node status, and decision about adjuvant chemotherapy for breast cancer.
    Velanovich V
    Am Surg; 1997 Apr; 63(4):330-3. PubMed ID: 9124752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment.
    Colleoni M; Viale G; Zahrieh D; Pruneri G; Gentilini O; Veronesi P; Gelber RD; Curigliano G; Torrisi R; Luini A; Intra M; Galimberti V; Renne G; Nolè F; Peruzzotti G; Goldhirsch A
    Clin Cancer Res; 2004 Oct; 10(19):6622-8. PubMed ID: 15475452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study.
    Elledge RM; Green S; Ciocca D; Pugh R; Allred DC; Clark GM; Hill J; Ravdin P; O'Sullivan J; Martino S; Osborne CK
    Clin Cancer Res; 1998 Jan; 4(1):7-12. PubMed ID: 9516946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone receptors in breast cancer and response to chemotherapy.
    Legha SS; Blumenschien GR; Buzdar AU; Hortobagyi GN
    N Engl J Med; 1979 May; 300(18):1053. PubMed ID: 431601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor determination and long term survival of patients with carcinoma of the breast.
    Crowe JP; Gordon NH; Hubay CA; Shenk RR; Zollinger RM; Brumberg DJ; McGuire WL; Shuck JM
    Surg Gynecol Obstet; 1991 Oct; 173(4):273-8. PubMed ID: 1925896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic value of estrogen and progesterone receptors in the operable breast cancer: results of a uni- and multifactorial analysis].
    Chevallier B; Heintzman F; Asselain B; Dauce JP; Bastit P; Graic Y; Brunelle P; Basuyau JP; Comoz M
    Bull Cancer; 1988; 75(1):23-36. PubMed ID: 3359056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity to first-line chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers.
    Kriege M; Seynaeve C; Meijers-Heijboer H; Collee JM; Menke-Pluymers MB; Bartels CC; Tilanus-Linthorst MM; Blom J; Huijskens E; Jager A; van den Ouweland A; van Geel B; Hooning MJ; Brekelmans CT; Klijn JG
    J Clin Oncol; 2009 Aug; 27(23):3764-71. PubMed ID: 19564533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of metastatic estrogen receptor and progesterone receptor status on survival.
    Lower EE; Glass EL; Bradley DA; Blau R; Heffelfinger S
    Breast Cancer Res Treat; 2005 Mar; 90(1):65-70. PubMed ID: 15770528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands].
    Voogd AC; Crommelin MA; Repelaer van Driel OJ; Tutein Nolthenius-Puylaert MC; Vreugdenhil G; Coebergh JW
    Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1772-8. PubMed ID: 9856143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic factors in the drug therapy of metastasizing breast cancer].
    Mörz R; Schemper M; Bettelheim P; Breyer S; Francesconi M; Graninger W; Jakesz R; Kolb R; Micksche M; Rainer H; Reiner G; Moser K
    Acta Med Austriaca Suppl; 1979; 6():319-22. PubMed ID: 299219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors affecting response to aminoglutethimide in advanced breast cancer.
    Brufman G
    Anticancer Res; 1993; 13(4):1235-7. PubMed ID: 8352549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.